EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Effects of monensin on morphogenesis and infectivity of Friend murine leukemia virus






Journal of Virology 42(3): 1067-1075

Effects of monensin on morphogenesis and infectivity of Friend murine leukemia virus

The transport of the gp70 glycoprotein to the cell surface and concomitant release of infectious virus was inhibited by treatment of Friend murine leukemia virus-infected Eveline cells with the sodium ionophore monensin. Virus yields were reduced more than 50-fold by 10(-5) M monensin, whereas particle production was reduced by 50% in monensin-treated cells. The resulting particles failed to incorporate newly synthesized gp70 and p15(E), whereas the other structural proteins, p30, p15, p12, and p10, were incorporated into virions. However, monensin did not inhibit the incorporation into virions of preformed gp70. A reduction in the efficiency of cleavage of the PrENV glycoprotein precursor and a defect in the processing of simple endo-H-sensitive to complex endo-H-resistant oligosaccharides suggest that intracellular transport of gp70 may be blocked before its entry into the Golgi apparatus. Fewer particles were found to bud from the cell surface, but intracellular vacuoles with budding virions were detected. Ferritin labeling and pulse-chase studies suggested a cell surface origin for these vacuoles. These experiments indicate that monensin inhibits the transport of Friend murine leukemia virus glycoproteins at an early stage, with a resultant block in the assembly and release of infectious virus.

(PDF 0-2 workdays service: $29.90)

Accession: 005314784

PMID: 7097856



Related references

Effects of monensin on morphogenesis and infectivity of murine leukemia virus. Abstracts of the Annual Meeting of the American Society for Microbiology 82: ABSTRACT T123, 1982

Infectivity of Friend murine leukemia virus for hamster cells. Journal of the National Cancer Institute 74(4): 905-908, 1985

Characterization of mono clonal antibodies reactive with murine leukemia viruses use in analysis of strains of friend mcf virus and friend ecotropic murine leukemia virus. Virology 127(1): 134-148, 1983

Sub genomic fragment of molecularly cloned friend murine leukemia virus dna contains the genes responsible for friend murine leukemia virus induced disease. Journal of Virology 35(3): 924-936, 1980

A 2.4-kilobase-pair fragment of the Friend murine leukemia virus genome contains the sequences responsible for friend murine leukemia virus-induced erythroleukemia. Journal of Virology 46(3): 718-725, 1983

Multipotential hemopoietic cell lines isolated from stem cell cultures infected with friend virus complex murine leukemia virus plus friend spleen focus forming virus show presence of murine leukemia virus but not friend spleen focus forming virus. Leukemia Research 10(2): 187-194, 1986

Cross-species infectivity and pathogenesis of the Friend murine leukemia virus complex in Syrian hamsters. Virus Research 130(1-2): 281-284, 2007

Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus. Virology 127(1): 134-148, 1983

Heteroduplex analysis of molecular clones of the pathogenic Friend virus complex: Friend murine leukemia virus, Friend mink cell focus-forming virus, and the polycythemia- and anemia-inducing strains of Friend spleen focus-forming virus. Journal of Virology 51(2): 306-314, 1984

Vaccinia virus recombinant expressing the envelope gene of friend murine leukemia virus protectively immunizes mice against friend virus induced leukemia. Brown, F , R M Chanock And R A Lerner (Ed ) New Approaches to Immunization: Developing Vaccines Against Parasitic, Bacterial, And Viral Diseases; Conference on Vaccines 86, Cold Spring Harbor, N Y , Usa Xxi+418p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 299-302, 1986